Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to
make changes to the treatment plan in order to accommodate changing circumstances …

Objective To analyze the impact of chronic kidney disease (CKD) on major clinical outcome
in SLE by using a nationwide database. Patients and methods Characteristics of all admitted …

The enumeration of EpCAM-positive circulating tumor cells (CTCs) has allowed estimation
of overall metastatic burden in breast cancer patients. However, a thorough understanding …

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous
system. Growing evidence has proven that T helper 17 (Th17) cells are one of the regulators …

Exosomal microRNAs (miRNAs) are emerging diagnostic biomarkers for neurodegenerative
diseases. In this study, we aimed to detect relapsing–remitting multiple sclerosis (RRMS) …

Glyphosate is a broad-spectrum herbicide that is used worldwide. It represents a potential
harm to surface water, and when commercially mixed with surfactants, its uptake is greatly …

BACKGROUND Siponimod (BAF312) is a selective sphingosine-1-phosphate receptor 1
and 5 (S1PR1, S1PR5) modulator recently approved for active secondary progressive …

MiRNAs were shown to participate in development of autoimmune inflammatory process in
multiple sclerosis (MS). To investigate miRNAs involvement in relapse-remission MS course …

CD39, an ectonucleotidase that hydrolyses pro-inflammatory ATP, is a marker of highly
active and suppressive T regulatory cells (Tregs). Although CD39 has a role in Treg …

Objectives Multiple sclerosis (MS) is a neurodegenerative disease characterised by
inflammation and damage to myelin sheaths. While all current disease‐modifying treatments …